ADAR1 Capital Management »

Promis Neurosciences shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Promis Neurosciences (PMN) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Promis Neurosciences

Tip: Access up to 7 years of quarterly data

All positions including Promis Neurosciences held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Promis Neurosciences by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.2M 95k 12.70

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Terns Pharmaceuticals Call Option (TERN)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Crinetics Pharmaceuticals In (CRNX)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Denali Therapeutics (DNLI)
Beam Therapeutics (BEAM)
Zai Lab Adr (ZLAB)
Septerna (SEPN)
Vir Biotechnology (VIR)
Dbv Technologies S A Sponsored Ads (DBVT)

View all positions for ADAR1 Capital Management

Top funds holding Promis Neurosciences

Henderson Group
Deep Track Capital
Trails Edge Capital Partners
Ally Bridge Group
Woodline Partners
Dr. Jeffrey R. Jay, M.D.
Yu Fan
Sphera Funds Management
Squadron Capital Management
ADAR1 Capital Management
683 Capital Management
Millennium Management
Empery Asset Management
Ikarian Capital
Boothbay Fund Management

View all funds holding Promis Neurosciences